- Home
- VIR vs DAVE Comparison
VIR vs DAVE Comparison
Compare VIR & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- DAVE
- Stock Information
- Founded
- VIR 2016
- DAVE 2017
- Country
- VIR United States
- DAVE United States
- Employees
- VIR N/A
- DAVE N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- DAVE Retail: Computer Software & Peripheral Equipment
- Sector
- VIR Health Care
- DAVE Technology
- Exchange
- VIR Nasdaq
- DAVE Nasdaq
- Market Cap
- VIR 706.4M
- DAVE 2.9B
- IPO Year
- VIR 2019
- DAVE N/A
- Fundamental
- Price
- VIR $5.23
- DAVE $204.60
- Analyst Decision
- VIR Strong Buy
- DAVE Strong Buy
- Analyst Count
- VIR 8
- DAVE 6
- Target Price
- VIR $30.25
- DAVE $237.50
- AVG Volume (30 Days)
- VIR 1.2M
- DAVE 551.1K
- Earning Date
- VIR 07-31-2025
- DAVE 08-04-2025
- Dividend Yield
- VIR N/A
- DAVE N/A
- EPS Growth
- VIR N/A
- DAVE N/A
- EPS
- VIR N/A
- DAVE 3.70
- Revenue
- VIR $20,861,000.00
- DAVE $381,425,000.00
- Revenue This Year
- VIR N/A
- DAVE $37.77
- Revenue Next Year
- VIR $0.62
- DAVE $18.45
- P/E Ratio
- VIR N/A
- DAVE $54.78
- Revenue Growth
- VIR N/A
- DAVE 39.31
- 52 Week Low
- VIR $4.32
- DAVE $28.74
- 52 Week High
- VIR $14.45
- DAVE $286.45
- Technical
- Relative Strength Index (RSI)
- VIR 51.12
- DAVE 41.67
- Support Level
- VIR $5.20
- DAVE $196.32
- Resistance Level
- VIR $6.23
- DAVE $286.45
- Average True Range (ATR)
- VIR 0.29
- DAVE 21.21
- MACD
- VIR 0.03
- DAVE -8.69
- Stochastic Oscillator
- VIR 38.08
- DAVE 5.94
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.